Skip to main content
ALLO logo

ALLO · Allogene Therapeutics, Inc.

$1.82 +0.16 (+9.34%)
Market Cap
$572.96M
Shares
345.15M

Institutional ownership from SEC Form 13F filings. Investment managers with more than $100 million in U.S. equities must disclose their positions every quarter, within 45 days of quarter-end, so the holdings shown can lag the market by up to a quarter.

The Jun 30, 2026 filing window is still open — showing the latest known positions. Funds that have not filed yet carry their prior-quarter positions; a fund that filed without this stock counts as sold out.
Holders: 208
Total Value: $446,707,680
Total Shares: 183,789,077
Showing 1–100 of 214 holdings by value · page 1 of 3

Institutional Ownership Trend

26 quarters

Holder Concentration

Across 207 13F filers
Top Holder
12.0%
Jun 2023 → Mar 2026 · range 11.2% – 20.7%
of institutional value
Top 5
42.0%
Jun 2023 → Mar 2026 · range 41.7% – 57.2%
of institutional value
Top 10
57.7%
Jun 2023 → Mar 2026 · range 57.7% – 75.4%
of institutional value
HHI
501
Jun 2023 → Mar 2026 · range 501 – 889
Broadly held
Showing 100 of 214
Export CSV
Holder Value (USD) % of 13F Shares Open
Key facts CIK 1737287 CUSIP 019770106 13F (30d) 32 filings 32 filers Visit website Investor relations